Purchase this article with an account.
Roswitha Seitz, Gregor Weber, Sebastian Albrecht, Rudolf Fuchshofer, Ernst R. Tamm, Andreas Ohlmann; Cross-Inhibition of Norrin and TGF-β Signaling Modulates Development of Retinal and Choroidal Vasculature. Invest. Ophthalmol. Vis. Sci. 2018;59(6):2240-2251. doi: 10.1167/iovs.17-23403.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Norrin is essential for the formation of the retinal vasculature during development and promotes its repair after damage via activation of Wnt/β-catenin signaling. Since retinal TGF-β signaling has essentially opposite effects on the retinal vasculature we investigated if and how Norrin inhibits TGF-β signaling, and vice versa.
Eyes from transgenic mice with an overexpression of Norrin (βB1-Norrin) and/or active TGF-β (βB1-TGF-β1) in the lens were generated and analyzed by light microscopy, immunohistochemistry, and TUNEL. Further on, protein as well as mRNA levels were investigated by Western blot analyses and real-time RT-PCR, respectively.
In βB1-TGF-β1 mice, the lack of retinal vascular development and choriocapillaris maintenance was rescued when transgenic Norrin was additionally overexpressed in the eye. In addition, retinal Wnt/β-catenin signaling and the levels of SMAD7, an inhibitor of the canonical TGF-β pathway, were substantially suppressed in retinae of βB1-TGF-β1 mice. In contrast, Norrin normalized Wnt/β-catenin signaling and SMAD7 levels in double transgenic mice. Moreover, in retinae of βB1-TGF-β1 mice, the amounts of phosphorylated SMAD3, a downstream mediator of TGF-β signaling, were increased compared to those of βB1-Norrin/βB1-TGF-β1 mice. In vitro, Norrin substantially reduced the TGF-β–mediated induction of target genes, an effect that was blocked by Dickkopf-1, a specific inhibitor of Wnt/β-catenin signaling.
High amounts of TGF-β in the eye cause a substantial reduction in the activity of Wnt/β-catenin signaling. This effect is inhibited in the presence of high amounts of Norrin, which further induce the expression of SMAD7 to inhibit TGF-β signaling.
This PDF is available to Subscribers Only